Image

Long-term Monitoring of Sleep With Ear-EEG in Patients With Chronic Pain

Recruiting
18 - 65 years of age
Both
Phase N/A

Powered by AI

Overview

Insomnia is reported by more than 50% of patients with chronic pain. In this study, the investigators aim to advance the understanding of physiological sleep in individuals with chronic pain. To do this the investigators will monitor at-home sleep with an ear-EEG over 20 nights in patients with chronic pain and collect self-reported measures of sleep and pain. The collected data will be used to explore and characterize intra-individual variations in sleep metrics (e.g. total sleep time, time in each sleep stage (N1, N2, N3, REM), sleep latency, REM stage latency, wake after sleep onset, sleep efficiency, number of arousals and arousal index) over 20 nights.

Eligibility

Inclusion Criteria:

For a subject to be eligible, all inclusion criteria must be answered "yes":

  • Understand and write Danish.
  • Pain present on most days or every day during the past 3 months.
  • Pain limits daily activities or work on some days, most days or every day during the past 3 months.
  • Pain intensity equal to or larger than 4 on 0-10 Numeric Rating Scale [NRS] within the last week.
  • Informed consent obtained before any study related activities.

Exclusion Criteria:

For a subject to be eligible, all exclusion criteria must be answered "no":

  • Previous stroke or cerebral haemorrhage and any other structural cerebral disease.
  • Obstructive sleep apnoea (Defined as yes to 3 or more questions in the STOP-BANG questionnaire for women and 4 or more questions for men).
  • Teeth grinding (bruxism).
  • Pregnancy or lactation (Pregnancy is screened for through self-reporting as no risks regarding pregnancy have been identified for the described study procedures).
  • Narrow or malformed ear canals or piercings, making ear-EEG infeasible.
  • Allergic contact dermatitis caused by metals or generally prone to skin irritation.
  • People judged incapable, by the investigator, of understanding the participant instruction or who are not capable of carrying through the investigation.

Study details

Chronic Pain, Insomnia

NCT06368531

Odense University Hospital

29 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.